Clinical Trials Research Group

Corina RueeggGroup leader
Corina Rueegg
Group leader

Clinical trials are the backbone of evidence-based medicine. Obtaining methodologically sound and valid answers to clinically relevant questions from clinical trials, is therefore of great importance. Ongoing methodological challenges in the field of clinical trials such as rare diseases, low compliance, low numbers of participants, necessity to treat, missing data, treatment heterogeneity, or an infectious disease setting, demand the development of novel methodological approaches. The aim of the Clinical Trials Research Group is therefore to conduct methodologically strong and high-quality randomized controlled trials (RCTs), identify relevant methodological problems and advance the research in the field, by developing, adapting and implementing new clinical trials methods. The close collaboration with the Clinical Trials Unit (CTU) helps us to identify relevant methodological challenges and gives us access to high-quality datasets.